ARROWHEAD PHARMACEUTICALS IN's ticker is and the CUSIP is 04280A950. A total of 4 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,238,707 | +23.2% | 46,100 | +63.5% | 0.00% | – |
Q2 2023 | $1,005,612 | +335.1% | 28,200 | +209.9% | 0.00% | – |
Q1 2023 | $231,140 | -92.4% | 9,100 | -87.9% | 0.00% | -100.0% |
Q4 2022 | $3,054,168 | -1.6% | 75,300 | -19.8% | 0.00% | 0.0% |
Q3 2022 | $3,103,000 | +1.4% | 93,900 | +8.1% | 0.00% | 0.0% |
Q2 2022 | $3,060,000 | – | 86,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 8,500 | $228,395 | 0.00% |
SIMPLEX TRADING, LLC | 6,000 | $161 | 0.00% |
JANE STREET GROUP, LLC | 46,100 | $1,238,707 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |